Thromboembolism
148
10
14
98
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
35 trials with published results (24%)
Research Maturity
98 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.4%
11 terminated out of 148 trials
89.9%
+3.4% vs benchmark
36%
53 trials in Phase 3/4
36%
35 of 98 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 98 completed trials
Clinical Trials (148)
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
Pregnancy and Risk of Venous Thromboembolism
Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement
CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer
Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
Strategies for Anticoagulation During Venovenous ECMO
ECMO Hemostatic Transfusions in Children
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery
DVT After Cardiac Procedure